Africa: Unicef Launches the Covid-19 Vaccine Market Dashboard

(file image).

New York — As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the COVID-19 Vaccine Market Dashboard - an interactive tool for countries, partners and industry to follow the developments of the rapidly evolving COVID-19 vaccine market and the efforts of the COVAX Facility to ensure fair and equitable access for every country in the world.

In this first release, the dashboard provides a regularly updated overview of the global research and development pipeline, the projected production capacity, publicly announced bilateral and multilateral supply agreements, as well as reported price points.

Once the ongoing joint UNICEF-PAHO tender on behalf of the COVAX Facility is complete, the dashboard will be expanded to provide visibility on progress towards the goal of the COVAX Facility to secure 2 billion vaccine doses by the end of 2021.

In 2021, the dashboard will provide an update on the status of procurement by UNICEF and other buyers participating in the COVAX Facility. It will also track the status of deliveries by UNICEF and other participating national and institutional buyers.

The COVID-19 Vaccine Market Dashboard is a testament to UNICEF's firm commitment to transparency, recognizing that the free flow of information and correcting information asymmetries is critical to underpin efficient markets.

More From: Unicef

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.